ETC
SAGE

Exchange Traded Concepts’s Sage Therapeutics SAGE Stock Holding History

Exchange Traded Concepts’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,663
Closed -$140K – 1261
2022
Q4 		$140K Buy
3,663
+914
+33% +$34.9K ﹤0.01% 736
2022
Q3 		$108K Buy
2,749
+346
+14% +$13.4K ﹤0.01% 740
2022
Q2 		$78K Buy
2,403
+1,555
+183% +$52.1K ﹤0.01% 827
2022
Q1 		$28K Buy
+848
New +$31.9K ﹤0.01% 997
2021
Q3 		– Sell
-285
Closed -$16K – 1214
2021
Q2 		$16K Buy
+285
New +$20.1K ﹤0.01% 1000
2021
Q1 		– Sell
-8,539
Closed -$739K – 1144
2020
Q4 		$739K Buy
+8,539
New +$629K 0.03% 271

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Exchange Traded Concepts's SAGE Position: Q1 2023 in Review

Exchange Traded Concepts sold out of Sage Therapeutics (SAGE) in Q1 2023, closing a stake of 3,663 shares — an estimated $140K sold.

Exchange Traded Concepts first reported a position in SAGE in Q4 2020 and held it in 6 quarters. The position peaked at $739K in Q4 2020. 213 funds tracked by Wall St. Rank hold SAGE as of Q1 2023.

  • Exchange Traded Concepts reported no remaining Sage Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Exchange Traded Concepts sold 3,663 Sage Therapeutics shares in Q1 2023, an estimated $140K.
  • Exchange Traded Concepts first reported a position in Sage Therapeutics in Q4 2020 and held it in 6 quarters.
  • Exchange Traded Concepts's Sage Therapeutics position peaked at $739K in Q4 2020.
  • 213 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2023.

Based on Exchange Traded Concepts's 13F filing for Q1 2023, filed 12 Apr 2023.